aspirin has been researched along with vapiprost in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (81.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuno, H; Nakashima, M; Takiguchi, Y; Uematsu, T; Umemura, K; Wada, K | 1 |
| Hirata, Y; Nakashima, M; Takiguchi, Y; Wada, K | 1 |
| Hubbell, JA; Wagner, WR | 1 |
| Keery, RJ; Lumley, P; Watts, IS; Wharton, KA; White, BP | 1 |
| Lumley, P; Watts, IS; Wharton, KA; White, BP | 1 |
| Danchin, N; Heyndrickx, GR; Mast, EG; Rensing, BJ; Rutsch, W; Serruys, PW; Stibbe, J; Vos, J; Wijns, W | 1 |
| Flores, NA; Goulielmos, NV; Seghatchian, MJ; Sheridan, DJ | 1 |
| Lumley, P; Sullivan, AT; White, BP | 1 |
| Hart, HH; Norris, RM; White, HD; Williams, BF | 1 |
| Hiraishi, S; Horie, S; Ishii, H; Kazama, M; Kizaki, K; Kurusu, O; Nakahara, T; Noritake, S; Satoh, M; Yamada, M | 1 |
| Guth, BD; Müller, TH | 1 |
| FitzGerald, GA; Habib, A; Maclouf, J | 1 |
| Kanamaru, M; Kozawa, O; Matsuno, H; Nagashima, S; Uematsu, T | 1 |
| Hokamura, K; Ikeda, Y; Kawano, KI; Kondo, K; Suzuki, Y; Umemura, K | 1 |
| Gairard, A; Gaubert, E; Matz, RL; Van Overloop, B | 1 |
| Gresele, P; Mezzasoma, AM; Venditti, G; Vezza, R | 1 |
2 trial(s) available for aspirin and vapiprost
| Article | Year |
|---|---|
Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARP
Topics: Angioplasty, Balloon, Coronary; Aspirin; Biphenyl Compounds; Constriction, Pathologic; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Heptanoic Acids; Humans; Male; Middle Aged; Receptors, Prostaglandin; Receptors, Thromboxane; Recurrence; Thromboxane A2 | 1991 |
Comparison of aspirin with a thromboxane antagonist for patients with prolonged chest pain and ST segment depression.
Topics: Aged; Aspirin; Biphenyl Compounds; Coronary Care Units; Double-Blind Method; Electrocardiography; Female; Heptanoic Acids; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Platelet Aggregation Inhibitors; Recurrence; Streptokinase; Thromboxane A2 | 1996 |
14 other study(ies) available for aspirin and vapiprost
| Article | Year |
|---|---|
Effects of vapiprost, a novel thromboxane receptor antagonist, on thrombus formation and vascular patency after thrombolysis by tissue-type plasminogen activator.
Topics: Animals; Aspirin; Biphenyl Compounds; Dose-Response Relationship, Drug; Heptanoic Acids; Injections, Intravenous; Male; Microscopy, Electron; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Thrombosis; Tissue Plasminogen Activator; Vascular Patency | 1992 |
Arterial thrombosis model with photochemical reaction in guinea-pig and its property.
Topics: Animals; Aspirin; Biphenyl Compounds; Disease Models, Animal; Femoral Artery; Fibrinolytic Agents; Guinea Pigs; Heptanoic Acids; Imidazoles; Light; Male; Microscopy, Electron, Scanning; Photochemistry; Platelet Aggregation; Prostaglandins; Rats; Rats, Wistar; Rose Bengal; Thrombosis | 1992 |
Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
Topics: Aspirin; Biphenyl Compounds; Blood Platelets; Citrates; Collagen; Heparin; Heptanoic Acids; Humans; In Vitro Techniques; Kinetics; Microscopy, Electron, Scanning; Platelet Adhesiveness; Receptors, Prostaglandin; Receptors, Thromboxane; Thrombosis; Thromboxane A2 | 1992 |
Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Biphenyl Compounds; Dose-Response Relationship, Drug; Epoprostenol; Heptanoic Acids; Humans; Male; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane B2 | 1991 |
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Topics: Aspirin; Biphenyl Compounds; Drug Interactions; Fatty Acids, Monounsaturated; Heptanoic Acids; Humans; Imidazoles; In Vitro Techniques; Male; Pentanoic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridines; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane-A Synthase | 1991 |
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Biphenyl Compounds; Blood Platelets; Colforsin; Diterpenes; Electrophysiology; Ginkgolides; Guinea Pigs; Heart; Heptanoic Acids; Lactones; Male; Myocardial Ischemia; Oxidopamine; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Yohimbine | 1994 |
Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
Topics: Anesthesia; Animals; Aspirin; Biphenyl Compounds; Blood Coagulation Tests; Coronary Circulation; Coronary Thrombosis; Dogs; Drug Synergism; Drug Therapy, Combination; Electric Stimulation; Female; Fibrinolytic Agents; Heptanoic Acids; Hirudin Therapy; Hirudins; Male; Platelet Aggregation; Recombinant Proteins; Thrombin; Thromboxane A2; Ticlopidine | 1994 |
The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets.
Topics: Adenosine Triphosphate; Animals; Arachidonic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Guinea Pigs; Heptanoic Acids; Humans; Male; Mice; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Rabbits; Rats; Rats, Wistar; Receptors, Thromboxane; Species Specificity; Thromboxane A2 | 1997 |
DTTX30, a combined thromboxane receptor antagonist and thromboxane synthetase inhibitor, prevents coronary thrombosis in anesthetized dogs.
Topics: Animals; Aspirin; Biphenyl Compounds; Chlorobenzenes; Coronary Thrombosis; Cyclooxygenase Inhibitors; Dogs; Enzyme Inhibitors; Female; Heptanoic Acids; Male; Platelet Aggregation Inhibitors; Pyridines; Receptors, Thromboxane; Thromboxane-A Synthase | 1997 |
Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.
Topics: Arachidonic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Electrophoresis, Polyacrylamide Gel; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Protein Kinase C; Receptors, Thromboxane; Thrombin; Thromboxane A2 | 1999 |
Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates.
Topics: Animals; Aspirin; Biphenyl Compounds; Cricetinae; Fibrinolytic Agents; Heptanoic Acids; Male; Piperazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis | 1999 |
Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
Topics: Amides; Animals; Anticoagulants; Aspirin; Biphenyl Compounds; Bleeding Time; Blood Platelets; Drug Synergism; Fibrinolytic Agents; Guinea Pigs; Hemorrhage; Heparin; Heptanoic Acids; Hindlimb; Male; Methacrylates; Middle Cerebral Artery; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thromboxane-A Synthase | 2001 |
Maturation reveals a decrease in endothelium-dependent contraction induced by depolarization in the aorta of spontaneously hypertensive rats.
Topics: Aging; Animals; Aorta; Aspirin; Biphenyl Compounds; Body Weight; Endothelium, Vascular; Heptanoic Acids; Hypertension; In Vitro Techniques; Muscle Contraction; Norepinephrine; Potassium Chloride; Prostaglandin Antagonists; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2 | 2001 |
Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aspirin; Biphenyl Compounds; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium Signaling; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Unsaturated; Heptanoic Acids; Humans; Hydrazines; Imidazoles; Inositol Phosphates; Kidney; Methacrylates; Phenylacetates; Platelet Activating Factor; Platelet Activation; Prostaglandin H2; Prostaglandins H; Protein Isoforms; Receptors, Thromboxane; Recombinant Fusion Proteins; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 2002 |